Topical application of mycophenolate mofetil prevents epidural fibrosis by inhibiting the proliferation and migration of fibroblasts

doi:10.12307/2022.256

Abstract

Abstract: BACKGROUND: Studies have shown that epidural fibrosis after laminectomy is mainly caused by the proliferation and migration of fibroblasts, and mycophenolate mofetil can inhibit the proliferation and migration of fibroblasts.
OBJECTIVE: To explore the effect of topical application of mycophenolate mofetil in preventing epidural fibrosis after laminectomy and its possible mechanism.
METHODS: (1) Cell test: Fibroblasts were separately treated with 0, 0.01, 0.1, 1, 10, and 100 μmol/L mycophenolate mofetil solution for 24 hours. Cell viability was detected by CCK-8 assay, and the appropriate treatment concentration was selected for subsequent cell experiments. Fibroblasts were separately treated with 0, 0.1, 1, 10 μmol/L mycophenolate mofetil solution for 24 hours. EdU assay and cell cycle assay were used to detect cell proliferation. Wound scratch assay and transwell assay were used to detect cell migration. Western blot assay was used to detect the expression of cell proliferation-related proteins (nuclear proliferation antigen, Cyclin D1) and migration-related proteins (α-tubulin, vinculin). (2) Animal test: Forty-eight adult SD rats were selected to construct rat laminectomy model and randomly divided into four groups. In the control group, cotton pads soaked with normal saline were placed on the postoperative bone defect area. In the low, medium, and high concentration groups, cotton pads soaked with 2.5, 5, and 10 g/L mycophenolate mofetil solution were placed on the postoperative bone defect area. Four weeks after the operation, the vertebral body of the operative area was taken for histological analysis.
RESULTS AND CONCLUSION: (1) Cell test results: CCK-8 assay showed that mycophenolate mofetil inhibited the viability of fibroblasts in a concentration-dependent manner. EdU assay showed that mycophenolate mofetil inhibited the proliferation of fibroblasts in a concentration-dependent manner. Flow cytometry showed that 0.1 μmol/L mycophenolate mofetil solution blocked the cell cycle in G0/G1 phase. Wound scratch assay and transwell assay showed that mycophenolate mofetil inhibited the migration of fibroblasts in a concentration-dependent manner. Western blot assay showed that mycophenolate mofetil inhibited the expression of fibroblast proliferation-related protein and migration-related protein in a concentration-dependent manner. (2) Animal test results: Histological observation showed that with the increase of mycophenolate mofetil concentration, the number of fibroblasts and collagen production in the fibrotic tissue of the surgical area gradually decreased. (3) The results showed that the topical application of mycophenolate mofetil after laminectomy can effectively prevent the occurrence of epidural fibrosis, possibly by inhibiting the proliferation and migration of fibroblasts.

Key words: material, mycophenolate mofetil, fibroblast, proliferation, migration, epidural fibrosis, animal, mouse, experiment

CLC Number:

Zhu Dongming, Zhang Zhen, Zhang Jie, Yan Lianqi. Topical application of mycophenolate mofetil prevents epidural fibrosis by inhibiting the proliferation and migration of fibroblasts[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(16): 2551-2556.

Figures/Tables 9

References

[1] KONG L, SHANG XF, ZHANG WZ, et al. Percutaneous endoscopic lumbar discectomy and microsurgical laminotomy : A prospective, randomized controlled trial of patients with lumbar disc herniation and lateral recess stenosis. Orthopade. 2019;48(2):157-164.
[2] SUN F, LIANG Q, YAN M, et al. Unilateral Laminectomy by Endoscopy in Central Lumbar Canal Spinal Stenosis: Technical Note and Early Outcomes. Spine. 2020;45(14):E871-E877.
[3] AVELLANAL M, DIAZ-REGANON G, ORTS A, et al. Transforaminal Epiduroscopy in Patients with Failed Back Surgery Syndrome. Pain Physician. 2019;22(1):89-95.
[4] ROGERSON A, AIDLEN J, JENIS LG. Persistent radiculopathy after surgical treatment for lumbar disc herniation: causes and treatment options. Int Orthop. 2019;43(4):969-973.
[5] SOBTI S, GROVER A, JOHN BPS, et al. Prospective Randomized Comparative Study to Evaluate Epidural Fibrosis and Surgical Outcome in Patients Undergoing Lumbar Laminectomy with Epidural Autologous Free Fat Graft or Gelfoam: A Preliminary Study. Int J Appl Basic Med Res. 2018;8(2):71-75.
[6] DAI J, SUN Y, CHEN D, et al. Negative regulation of PI3K/AKT/mTOR axis regulates fibroblast proliferation, apoptosis and autophagy play a vital role in triptolide-induced epidural fibrosis reduction. Eur J Pharmacol. 2019;864:172724.
[7] KIKUCHI K, SETOYAMA K, TERASHI T, et al. Application of a Novel Anti-Adhesive Membrane, E8002, in a Rat Laminectomy Model. Int J Mol Sci. 2018;19(5):1513.
[8] ZENG L, SUN Y, LI X, et al. 10‑Hydroxycamptothecin induces apoptosis in human fibroblasts by regulating miRNA‑23b‑3p expression. Mol Med Rep. 2019;19(4):2680-2686.
[9] ANDERSON KD, BRYDEN AM, MOYNAHAN M. Risk-benefit value of upper extremity function by an implanted electrical stimulation device targeting chronic cervical spinal cord injury. Spinal Cord Ser Cases. 2019;5(1):68.
[10] TACCOLA G, BARBER S, HORNER PJ, et al. Complications of epidural spinal stimulation: lessons from the past and alternatives for the future. Spinal cord. 2020;58(10):1049-1059.
[11] 李杨.吡非尼酮抑制大鼠皮肤切口瘢痕形成的实验研究[D].合肥:安徽医科大学,2019.
[12] 佟格霏.A型肉毒毒素抑制增生性瘢痕成纤维细胞生物学功能的实验研究[D].大连:大连医科大学,2019.
[13] 杨春兰.霉酚酸酯在肾移植中的治疗药物监测研究及基因多态性的影响[D].合肥:安徽医科大学,2017.
[14] MORATH C, SCHWENGER V, BEIMLER J, et al. Antifibrotic actions of mycophenolic acid. Clin Transplant. 2006;20:25-29.
[15] ZHANG C, CHAN CCY, CHEUNG KF, et al. Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis. Clin Sci. 2019; 133(15):1721-1744.
[16] 朱忠华,张春,邓安国,等.霉酚酸酯抑制大鼠肾间质纤维化的研究[J].中华肾脏病杂志,2002,18(4):61-63.
[17] 周晓霜.根据细胞周期联合使用他克莫司和霉酚酸酯治疗系膜增生性肾病的实验研究[D].太原:山西医科大学,2015.
[18] XIE F, LI X, SUN K, et al. An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage. J Tradit Chin Med. 2001;21(3):225-231.
[19] KNAPP S, BERTELMANN E, HARTMANN C, et al. Intraocular availability of topically applied mycophenolate mofetil in rabbits. Journal of ocular pharmacology and therapeutics. 2003;19(2):181-192.
[20] XIONG G, CHEN H, WAN Q, et al. Emodin promotes fibroblast apoptosis and prevents epidural fibrosis through PERK pathway in rats. J Orthop Surg Res. 2019;14(1):319.
[21] ISMAILOGLU O, KIZILAY Z, CETIN NK, et al. Effect of Curcumin on the Formation of Epidural Fibrosis in an Experimental Laminectomy Model in Rats. Turk Neurosurg. 2019;29(3):440-444.
[22] VEDIAPPAN RS, MASCARENHAS A, NGUYEN-HOANG A, et al. Prevention of peridural adhesions in spinal surgery: Assessing safety and efficacy of Chitogel with Deferiprone in a sheep model. J Clin Neurosci. 2020; 72:378-385.
[23] ERDOGAN B, IS M, AKER FV, et al. Preventative effect of diclofenac sodium and/or diltiazem in rats with epidural fibrosis. Bratisl Lek Listy. 2019;120(11):813-818.
[24] KESER N, IS M, CEMAN D, et al. Locally Used Antibiotics for Spinal Infection Prophylaxis and Their Effects on Epidural Fibrosis: an Experimental Laminectomy Study in Rats Using Rifamycin and Gentamycin. Inflammation. 2019;42(2):714-720.
[25] WU Y, LIU D, ZHOU Q, et al. Effect of surface microstructure on the anti-fibrosis/adhesion of hydroxyapatite ceramics in spinal repair of rabbits. J Biomed Mater Res. Part B, Applied biomaterials. 2019;107(8):2629-2637.
[26] ALBIÑANA-CUNNINGHAM JN, RIPALDA-CEMBORÁIN P, LABIANO T, et al. Mechanical barriers and transforming growth factor beta inhibitor on epidural fibrosis in a rabbit laminectomy model. J Orthop Surg Res. 2018;13(1):72.
[27] YANG L, GAO Q, LV F, et al. miR‑519d‑3p promotes TGFβ/Smad mediated postoperative epidural scar formation via suppression of BAMBI. Mol Med Rep. 2019;20(4):3901-3909.
[28] PIYASIRIDEJ S, TOWNAMCHAI N, UDOMKARNJANANUN S, et al. Plasmapheresis Reduces Mycophenolic Acid Concentration: A Study of Full AUC(0-12) in Kidney Transplant Recipients. J Clin Med. 2019;8(12): 2084.
[29] DUARTE AC, SANTOS MJ, CORDEIRO A. Anti-fibrotic nintedanib-a new opportunity for systemic sclerosis patients? Clin Rheumatol. 2018;37(4):1123-1127.
[30] SCHEEL PJ JR, FEELEY N, SOZIO SM. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med. 2011;154(1):31-36.
[31] YUNG S, ZHANG Q, CHAU MK, et al. Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice. Autoimmunity. 2015;48(7):471-487.
[32] WANG QJ, ZHANG AL, KANG ZQ, et al. Exogenous IL-19 mediates downregulation of TGF-β through Erk and p38 pathway to inhibit epidural fibrosis. Eur Rev Med Pharmacol Sci. 2019;23(17):7184-7190.
[33] BAGCI G, YÜCEL I, DURANOGLU Y. The effect of cyclosporin A on cultured rabbit subconjunctival fibroblast proliferation. Ophthalmologica. 1999;213(2):114-119.
[34] YILDIZ KH, GEZEN F, IS M, et al. Mitomycin C, 5-fluorouracil, and cyclosporin A prevent epidural fibrosis in an experimental laminectomy model. Eur Spine J. 2007;16(9):1525-1530.
[35] 戴纪杭.羟基喜树碱通过调控NOXA表达预防椎板切除术后硬膜外瘢痕粘连的研究[D].扬州:扬州大学,2017.
[36] LI X, WANG S, DAI J, et al. Homoharringtonine prevents surgery-induced epidural fibrosis through endoplasmic reticulum stress signaling pathway. Eur J Pharmacol. 2017;815:437-445.